Βιογραφικό
Σωτήρη Κ. Αδαμίδη

PERSONAL INFORMATION

  • Director Department of Internal Medicine, Athens Medical Center

  • 5-7 Distomou Street 15125 Maroussi Athens Greece

  • +30210 6157107 fax : +30 210 6120977

  • Private office : 40 Thisseos Street Maroussi Athens Greece, 15124

  • +30210 8069971 fax : +30210 6109028

  • mobile : + 30 6934 30 49 93

  • e-mail : adamidis@yahoo.com

EDUCATION

1971-1978

Medicine Athens Medical School, Athens University

1978-1980

Greek Army, Health Department

1980-1983

Director : Akrata’s Health Center, Patra, Greece

1984-1986

Residency : IM ,CD, PUD, University of Athens, Athens ,Greece

1984-1988

Ph.D. Athens University, School of Medicine, Department of Pathologic Physiology «Dissertation title : β-thromboglobulin and platelet factor-4 plasma levels in steady state sickle cell patients and those on crisis.» Dissertation director : Professor Anthi Travlou

PROFESSIONAL EXPERIENCE

1977-1978

Graduate Teaching Assistant, Department of Path ophysiology

1984-1986

Teaching Assistant, 1st Department of Internal Medicine, Athens University, Athens

1984-1986

Research Assistant Department of Pathophysiology Athens University, Athens

1986-present

Private Practice, Internal Medicine, Athens

1990-present

Director, Athens Medical Center Hospital, Internal Medicine Department, Athens

HONORS AND AWARDS

  • Fellow International Academy of Chest Physician and Surgeon’s, American College of Chest Physicians.

  • American Heart Association, Council member.

  • Scientific Council : Clinical Cardiology. (AHA)

  • American Diabetes Association.

  • American Hypertension Society.

  • Vista Link International Medical Consultants Network member. (internet based continuing medical education program development)

  • Editorial Advisory Board, Vita, 1999-2001.

  • Editorial Advisory Board, Medical World, 1996-present.

  • Hellenic Society of Internal Medicine.

  • Hellenic Thoracic Society.

  • Hellenic anti Cancer Society.

  • American College of Chest Physicians.

  • Chron’s and Colitis Foundation of America.

  • European Association for the Study of Obesity.

  • American Association of Clinical Endocrinologists.

  • Chairman of scientific protocol approval committee, Athens Medical Center.

  • Chairman of the scientific Society of Athens Medical Center.

  • Chairman of scientific committee on medicinal products, Athens Medical Center.

  • The American Biographical Institute (since:2005).

  • Hellenic Medical Assosiation for Obesity.

  • Heart Failure Association – The European Society of Cardiology.

  • American Stroke Association / Vascular Biology Member.

  • Behavioral Medicine and Biology – ASC.

PUBLISHED ARTICLES

  • Application of full therapy with the administration of primaquine in malaria from P. falciparum in countries where the anopheles is endemic but not the disease. Nicosia, Cyprus. / G. Panos , A. Greka, A. Nastos , G. Tsikkinis, M A Astriti, E. Giannatou, S. Adamidis. 1st Cyprus Congress of Chemotherapy and Infectious Diseases, 31/3 – 2/4/2000.

  • Statistical model depicting the rate of change of CD4 cells and viral load from initiation of antiretroviral therapy in experienced HIV (+) Patients. I. Karidis, I. Giannakopoulou, A. Trikalinou, E. Giannatou, S. Adamidis, V. Vasdekis, G. Panos. 13th Panhellenic AIDS Congress, page 52, Athens Oct/Nov 2001

  • Total recording of primary and secondary mutations in HIV seropositive patients ; a comparison with the international bibliographic data E. Giannatou, I. Karidis, A. Trikalinou, S. Adamidis, G. Panos. Hellenic Archives of AIDS, Vol .9, Issue 2, page 89-92, 2001.

  • Record of primary and secondary mutations of ZDV and LMV in HIV seropositive patients ; comparison with the international bibliographic data. E. Giannatou, Trikalinou A, I. Karidis, S. Adamidis, G. Panos.

  • Genotypic profile of primary and secondary mutations in Greek HIV (+) patients with virologic success while they receive a new HAART combination E. Giannatou, Trikalinou A, I. Karidis, S. Adamidis, G. Panos HIV Unit, 1st IKA Hospital, Athens, Greece. 13th, Panhellenic AIDS Congress, p.54 Athens Oct/Nov 2001.

  • Fluctuation of viral load under new salvage antiretroviral treatment in multiresistant-multiexperienced to protease inhibitors HIV (+) patients . I.Karides, A. Trikalinou, A.Filandras, S .Melenikli, S. Adamidis , G.Panos. HIV Unit 1st IKA Hospital 13th Panhellenic AIDS Congress ,p . 65, Athens Oct/Nov 2001.

  • Fluctuation of CD4 under new salvage antiretroviral treatment in multiresistant-multiexperienced to protease inhibitors HIV (+) patients . I.Karides, A. Trikalinou, A.Filandras, S .Melenikli, S. Adamidis , G.Panos. HIV Unit 1st IKA Hospital 13th Panhellenic AIDS Congress ,p . 66, Athens Oct/Nov 2001.

  • Co- existence of cutaneous and visceral Leismaniasis in a HIV seropositive patient. A. Trikalinou, I.Karides, Giannatou E, A.Filandras, S. Adamidis ,G.Kontelis , G.Panos. HIV Unit 1st IKA Hospital 13th Panhellenic AIDS Congress ,p . 67, Athens Oct/Nov 2001.

  • Double protease ( PI ) and NNR1( Iopinavir/Vitozevir/Saquinavir-HG/Delaverdine) as a successful salvage therapy in HIV (+) patients with lactic acidosis and multiple genotypic resistance in NNRTIs and PIs A. Roussou , F. Syrrokosta, I. Karides, S. Melenikli, S. Adamidis, G. Panos HIV Unit ,1st IKA Hospital,Penteli ,Athens . Common 18th Pancyprian Medical Congress and 2nd Pancyprian Congress of Chemotherapy and Infectious Diseases, 12-15 Sept 2002, Nicosia Cyprus, p. 28, No 10.

  • Cystic adenomatoid hyperplasia of an embryo in a HIV (+) pregnant woman receiving HAART from the 10th week of pregnancy and for 4 weeks when the diagnosis was made . A. Roussou , F. Syrokosta,I. Karides,S.Melenikli, S.Adamidis,D. Haritatos,D.Papanikolaou,G.Panos Common 18th Pancyprian Medical Congress and 2nd Cyprus Congress of Chemotherapy and Infectious Diseases, 12-15 Sept 2002, Nicosia Cyprus, p. 33, No 17.

  • Staphylococcus hominis infection in a HIV(+) patient receiving HAART with pyoderma and respiratory infectia

  • “Inhale drug consumption and asthma mortality in Greece”, CHEST –Volume 107, June 6 ,1995

  • “A case of diabetes following tibolone therapy”, MATURITAS – December 1993

  • “Evaluation of metaholine bronchial provocation test in asthmatics” Kioto,-Japan, October 1991

  • “A study of β-thromboglobulin and platelet factor -4 plasma levels in steady state sickle cell patients.” Blut , July 11, 1990

  • “Nocturnal Asthma and biological (circadian) rhythms”, Greek Medical Chronicles , Volume 1984

  • High incidence of celiac disease in Greek patients with digestive symptoms” 9th Pan-Hellenic congress of internal medicine, October 6-11,2003 Athens

  • “Automatic pneumomediastinum in adults 20 years” ” 12th Pan-Hellenic congress of Pulmonary Diseases, December 3-7,2003 Athens

BOOKS PUBLISHED

  • Patristic Therapeutics and Psychoanalysis Stamoulis publications,university press , 2002Athens Greece

  • Obesity ,Metabolic Syndrome and Diabetes, 2010 Stamoulis Publ. 2010, Athens Greece

PRESENTATIONS AS A SPEKEAR IN NATIONAL AND INTERNATIONAL CONGRESS

  • Hellenic Lipid Management Series ,Amirandes , Herakleion , Greece Managing Cholesterol Levels: Awareness, Treatment , and Control Of Hypercholesterolaemia May 2005

  • «Recent developments in prevention and treatment of cardiovascular risk/ hypertension and hyperlipidemia» June 26,2006 Greece

  • Sildenafil plus Atorvastatin in patients with Metabolic Syndrome and Erectile Dysfunction: Effectiveness and safety Issues. Vascular Biology Working Group meeting. October 19 , 2006 , Milan Italy

  • The role of TZDs in the prevention and treatment of T2D 10 years history of TZDs, Important Data for Clinical Practice. Nov 19 ,2010 , Krakovia Polland International Endocrinogy Congress

  • Pathophysiology of T2D .Insulin Resistance and Beta Cell Function .The role of sitagliptin in the therapeutic Algorythm Aldemar ,Olympia , Greece .Sept 30,2011.

NATIONAL AND INTERNATIONAL CONGRESSES

  • “A new oral therapy for pulmonary arterial hypertension via phosphodiesterase-5 (PDE 5 ) inhibition” 12th October

  • “ESC Congress 2004” September 2004, Munich – Germany

  • “XVIIth Congress of the European Society of Cardiology”Amsterdam Netherlands 19-24 August 1995

  • XXIIth Congress of the European Society of Cardiology” Netherlands 26-30 August 2000

  • “66th Scientific Session – American Diabetes Association Annual Meeting” 9-13 June 2003 – Washington

  • “Towards a better outcome in the management of UCAD” Open live telesymposium, Thursday 12 December 1996

  • International Diabetes Federation – Le Palais de Congress, Paris 24-29 August 2003

  • “1st Balkan Congress on Obesity – 5th Pan-Hellenic Medical Congress on Obesity” February 6-9,2003 Athens Greece

  • “6th International Symposium on “Global Risk of Coronary Heart Disease and Stroke: Assessment, Prevention and Treatment” Florence, June 12-15,2002

  • International Association of Obesity, International Diabetes Federation “ Orchestrating Success” Berlin, March 25-28,2004

  • “International Symposium “ Calcium antagonism plus beta- blockade – opposites or synergism?”

  • “XXth Congress of the European Society of Cardiology” 22-26 August 1998 – Vienna

  • “State of Heart Protection: New Clinical Developments in the treatment of Coronary Heart Disease” Seville, Spain, February 22-23, 2002

  • “Scientific Symposium cox –II inhibition- A clinical Update on Safety and Efficacy” London, April 2001

  • “XXIst Congress of the European Society of Cardiology” 22-26 August 1999 – Barcelona- Spain

  • “11th Scientific Meeting of the American Society of Hypertension” May 15-18,2006 –New York, USA

  • “Interaktion oder Synergismus zwischen Beta-Rezeptorenblockern und NOCTAMID” August 1984, Deutschland

  • “The second international postgraduate medical symposium, Advances in Cardio-Pulmonary medicine” Salzburg, February 2nd,1989

  • “64th Scientific Session, June 4-8,2004” Orlando, Florida

  • “The 13th European Congress on Obesity” Prague – Czech Republic, May 26-29,2004

  • “74th European Atherosclerosis Congress”, April 17-20,2004

  • “World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy). October 26-29, 2007.

  • RC33 6th International Conference on Social Science Methodology 2004.

  • “Targeting Cardiovascular Disease in Type 2 Diabetes: Making the Link” 22-24 April, 2004 –Athens, Greece

  • “18th Conference of the International Diabetes Federation” Paris, 24-29 August 2003

  • “XV International Congress of Allergology and Clinical Immunology” Annual Meeting, June 26- July 1, 1994 Stockholm – Sweden

  • “XIV International Congress of Allergology and Clinical Immunology” Annual Meeting, October 13-18, 1991

  • “Epidemiology Safety Evaluation of Losec Therapy in patients of Northern Attica” , June 22,1999 – Northern Attica

  • “The Second International Postgraduate Medical Symposium –Advances in Cardio-Pulmonary” January 30th – February 2nd, 1989, Salzburg – Austria

  • “74th EAS Congress” March 18th, 2004 , Seville- Spain

  • “Sildenafil plus atrovastatin in patients suffering from E.O. and metabolic syndrome” European Chapter Meeting, October 20-21, Milan, Italy

  • “The acute effect of wood coal production on pulmonary function” ESR Annual Congress, September 25th – 29th, 1993, Firenze, Italy

  • “Hypertension and Cardiovascular Risk”, Thessaloniki ,March 14-16, 2002

  • “New data in the treatment of chronic diseases of the digestive system and application in daily clinical practice” March 10-11,2007 – Greece

  • “High incidence of celiac disease in Greek patients with digestive symptoms” 9th Pan-Hellenic congress of internal medicine, October 6-11,2003 Athens

  • Automatic pneumomediastinum in adults 20 years” ” 12th Pan-Hellenic congress of Pulmonary Diseases, December 3-7,2003 Athens

  • “A study of β-thromboglobulin and platelet factor -4 plasma levels in steady state sickle cell patients.” 2nd Pan-Hellenic Hematology Congress, November 1-3,1985- Athens

  • “Fibrous dysplasia of temporal bone” 10th Pan-Hellenic Otolaryngology Congress, October 6-10,1999 – Greece

RESEARCH ACTIVITY – SCIENTIFIC PROTOCOLS

  • “ Flu Surveillance Program” Tamiflu, Roche Global Team , 1999-2000

  • Training Program Director in Clinic of Internal Medicine in Athens Medical Center

  • Training Program Director in Clinic of Internal Medicine in Semmelweis University , Budapest

  • “Treatment of peptic ulcer with famotidine” (a multicenter study in Greece), Adamidis S. et all

  • “Multicenter study evaluating the clinical efficacy and safety of cefprozil in the treatment of infections of lower respiratory tract” , Adamidis S. et all

  • “Changes in systolic blood pressure index after antihypertensive treatment with quinapril”

  • «Clinical assessment of lipid profiles in patients with type 2 diabetes receiving combined oral treatment»

  • “Program of clinical practice in pharmacy school graduates – MCs in Clinical Practice”2001-2002/2004-2005